BVS vs RJF · rev $285.3M vs rev $15.91B
Bioventus Inc (BVS) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
RJF (RJF) common stock.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
BVS currently screens at market cap $495.1M. RJF currently screens at market cap $0.
Not investment advice. Open the BVS and RJF stock pages for the full models.
Not investment advice.